Next Implementation Steps Unclear After EU Parliament Votes to Support IVD Regulation Review
Premium
The parliamentary resolution drew the immediate support of MedTech Europe and VDGH, but it remains unclear what the immediate outcome of the resolution will be.
Backed by $184M in Recent Funding, Cytovale Aims to Bring Its Sepsis Risk Test Into More ERs
Premium
The firm said that demand has increased for its 10-minute sepsis risk test as it can save lives, reduce hospital stays, and reduce healthcare costs.
The researchers used publicly available data from companies such as Guardant Health, Exact Sciences, and Geneoscopy to determine possible effects of blood-based tests.
The company believes that it has threaded the needle in terms of providing the maximum of necessary information to clinicians, while maintaining a rapid turnaround time.
Several new studies appear to confirm the test's potential to prevent overtreatment of melanoma patients while identifying those at high risk.
The company's Diagnostics and Spatial Biology business saw 14 percent growth in the quarter, while the Protein Sciences segment's revenues were essentially flat.